Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments.

@article{Kedem2013AntiMllerianH,
  title={Anti-M{\"u}llerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments.},
  author={Alon Kedem and Ariel Hourvitz and Yuval Yung and Libby Shalev and Gil M. Yerushalmi and Hannah Kanety and Mirit Hanochi and Ettie Maman},
  journal={Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology},
  year={2013},
  volume={29 7},
  pages={651-6}
}
PURPOSE To prospectively study the AMH expression and secretion pattern in mural granulosa cells (GCs) and follicular fluid (FF) from small follicles and medium follicles that were collected from normo-ovulatory (NO) and polycystic ovary syndrome (PCOS) patients undergoing in vitro maturation (IVM) treatments. METHODS FF AMH levels and mRNA expression of mural GCs were measured in small (≤ 10 mm) and medium size follicles (11-15 mm) obtained from IVM treatments and large size follicles (≥ 16… CONTINUE READING
7 Citations
0 References
Similar Papers

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…